ANTI-IGFBP3 (C-TERM)

Not available outside of the UK & Ireland.

Immunogen

synthetic peptide selected from the C-terminal region of human IGFBP3 (a.a. 262-295), KLH conjugated.

Physical form

Supplied in PBS with 0.09% (W/V) sodium azide.

Target description

IGFBP3 is a member of the insulin-like growth factor binding protein (IGFBP) family with an IGFBP domain and a thyroglobulin type-I domain. This protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors.